tirzepatide osa study sleep apnea and glp-1 medication is known to improve apnea, but not all patients Breakthrough Treatment for Obstructive Sleep

Access this article Similar content being viewed by others Data Availability The data that support the findings of this study are available from the corresponding author (Peixoto C.A.) upon request

PMID: 30909904, PMCID: PMC6432744, DOI: 10.1186/s12913-019-4018-0

Most centers require you to be symptom-free for at least 24 to 48 hours

According to McGowan: Anyone with baseline reduced muscle mass should be cautious when starting a GLP-1 medication

Notably, compared with visceral fat, subcutaneous fat, which accounts for up to 90% of total body fat, is a more accurate predictor of reduced brain volume

In practice, access now depends on clinician judgment